PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.\', \'Department of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.\', \'Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan.\', \'Department of Math and Science, Community College of Qatar, Doha, Qatar.\', \'Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.\', \'Qatar Metabolic Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.\', \'The Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.\', \'Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.\', \'Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman.\', \'Biomedical Research Centre, School of Science, Engineering and Environment, University of Salford, Manchester, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.707159
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34966381
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34966381>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34966381>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all